WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel...
Rakuten Medical, Inc. has elected to discontinue use of the name "Illuminox," and to start using a new, evolved name "Alluminox™" for our proprietary,...
The U.S. Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef...
LongPath Technologies, Inc. and Apache Corporation are announcing an expansion of their partnership for continuous methane emissions monitoring in the Permian Basin of southeast...
SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is opening a 175 square meter state-of-the-art BSL2/GMO2-classified laboratory in Copenhagen. The new facilities...
